Canada Life
AMED

Canada Life’s Amedisys AMED Stock Holding History

Canada Life’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-21,288
Closed -$2.09M – 1916
2025
Q2 		$2.09M Sell
21,288
-1,498
-7% -$142K ﹤0.01% 1177
2025
Q1 		$2.11M Sell
22,786
-1,341
-6% -$124K ﹤0.01% 1167
2024
Q4 		$2.19M Sell
24,127
-1,879
-7% -$173K ﹤0.01% 1227
2024
Q3 		$2.51M Buy
26,006
+702
+3% +$68.5K ﹤0.01% 1202
2024
Q2 		$2.32M Buy
25,304
+1,359
+6% +$126K ﹤0.01% 1209
2024
Q1 		$2.21M Sell
23,945
-3,923
-14% -$368K ﹤0.01% 1196
2023
Q4 		$2.64M Sell
27,868
-118,344
-81% -$11.1M 0.01% 1100
2023
Q3 		$13.7M Buy
146,212
+114,209
+357% +$10.6M 0.03% 460
2023
Q2 		$2.93M Sell
32,003
-118,506
-79% -$9.72M 0.01% 996
2023
Q1 		$10.9M Buy
150,509
+28,652
+24% +$2.48M 0.03% 504
2022
Q4 		$10.2M Sell
121,857
-844
-0.7% -$76.1K 0.03% 513
2022
Q3 		$11.9M Buy
122,701
+678
+0.6% +$80.8K 0.03% 468
2022
Q2 		$12.8M Buy
122,023
+23,237
+24% +$2.97M 0.03% 469
2022
Q1 		$17.1M Buy
98,786
+82,289
+499% +$12.3M 0.04% 451
2021
Q4 		$2.67M Buy
16,497
+1,150
+7% +$185K 0.01% 1044
2021
Q3 		$2.31M Buy
15,347
+2,450
+19% +$509K 0.01% 1093
2021
Q2 		$3.15M Buy
12,897
+5
+0% +$1.31K 0.01% 875
2021
Q1 		$3.41M Sell
12,892
-6,897
-35% -$1.95M 0.01% 828
2020
Q4 		$5.81M Sell
19,789
-1,820
-8% -$467K 0.01% 750
2020
Q3 		$5.11M Sell
21,609
-737
-3% -$168K 0.01% 708
2020
Q2 		$4.43M Buy
22,346
+754
+3% +$141K 0.01% 725
2020
Q1 		$3.96M Buy
21,592
+5,857
+37% +$1.04M 0.01% 705
2019
Q4 		$2.61M Buy
+15,735
New +$2.34M 0.01% 973
2019
Q3 		– Sell
-17,774
Closed -$2.16M – 1162
2019
Q2 		$2.16M Buy
+17,774
New +$2.11M ﹤0.01% 1133
2019
Q1 		– Sell
-38,472
Closed -$4.16M – 2595
2018
Q4 		$4.16M Buy
38,472
+1,736
+5% +$205K 0.01% 700
2018
Q3 		$4.59M Hold
36,736
– – 0.01% 732
2018
Q2 		$3.14M Sell
36,736
-1,204
-3% -$88.4K 0.01% 899
2018
Q1 		$2.29M Sell
37,940
-142
-0.4% -$8.09K 0.01% 1060
2017
Q4 		$2.01M Sell
38,082
-950
-2% -$50.1K ﹤0.01% 1173
2017
Q3 		$2.17M Sell
39,032
-2,150
-5% -$114K 0.01% 1086
2017
Q2 		$2.58M Buy
41,182
+1,120
+3% +$65.2K 0.01% 966
2017
Q1 		$2.04M Buy
40,062
+2,960
+8% +$141K 0.01% 1123
2016
Q4 		$1.58M Sell
37,102
-926
-2% -$39.4K ﹤0.01% 1236
2016
Q3 		$1.8M Buy
38,028
+725
+2% +$36.2K 0.01% 1112
2016
Q2 		$1.88M Buy
37,303
+33,708
+938% +$1.7M 0.01% 1052
2016
Q1 		$173K Hold
3,595
– – ﹤0.01% 1399
2015
Q4 		$141K Hold
3,595
– – ﹤0.01% 1511
2015
Q3 		$137K Buy
3,595
+2,300
+178% +$97K ﹤0.01% 1471
2015
Q2 		$51K Hold
1,295
– – ﹤0.01% 2202
2015
Q1 		$35K Hold
1,295
– – ﹤0.01% 2217
2014
Q4 		$38K Hold
1,295
– – ﹤0.01% 2190
2014
Q3 		$26K Hold
1,295
– – ﹤0.01% 2253
2014
Q2 		$22K Hold
1,295
– – ﹤0.01% 2216
2014
Q1 		$19K Hold
1,295
– – ﹤0.01% 2139
2013
Q4 		$19K Buy
+1,295
New +$20.9K ﹤0.01% 2138

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Canada Life's AMED Position: Q3 2025 in Review

Canada Life sold out of Amedisys (AMED) in Q3 2025, closing a stake of 21,288 shares — an estimated $2.09M sold.

Canada Life first reported a position in AMED in Q4 2013 and held it in 45 quarters. The position peaked at $17.1M in Q1 2022. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Canada Life reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Canada Life sold 21,288 Amedisys shares in Q3 2025, an estimated $2.09M.
  • Canada Life first reported a position in Amedisys in Q4 2013 and held it in 45 quarters.
  • Canada Life's Amedisys position peaked at $17.1M in Q1 2022.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Canada Life's 13F filing for Q3 2025, filed 17 Nov 2025.